Literature DB >> 3933822

Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.

F Yoshimoto, S Masuda, T Higashi, T Nishii, I Takamisawa, N Tateishi, Y Sakamoto.   

Abstract

Donryu strain albino rats were maintained on a diet containing 0.06% 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) for nine successive generations. Some rats in the fourth to eighth generations showed marked resistance to the carcinogenic action of 3'-Me-DAB. In the liver where we found tumors, their size and number are smaller than in the corresponding original strain of rats fed on a diet containing 3'-Me-DAB. No significant differences were found in the total cytochrome P-450 contents or epoxide hydrolase activities of the livers of the resistant variant and the original strain, but the benzo(a)pyrene hydroxylase activity which is mainly attributed to cytochrome P-448 and glutathione S-transferase activity of the resistant variant were lower. The inductions of hepatic cytochrome P-488 and benzo(a)pyrene hydroxylase on administration of polychlorinated biphenyls or 3-methylcholanthrene were also lower in the resistant rats. In the mutagenicity test on Salmonella typhimurium TA 98 the liver 9000 X g supernatant fraction from 3'-Me-DAB-resistant F7 rats did not fully induce the mutagenicities of 3'-Me-DAB and several other carcinogens. Thus the resistance of F7 rats to the chemical carcinogen may be related to the lower activities of some drug-metabolizing enzymes and the poor inducibility of cytochrome P-448 in their liver, although selection of resistant rats should be continued for further generations before coming to a definite conclusion on biochemical basis of apparent resistance to 3'-Me-DAB.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933822

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.

Authors:  Takahiro Gotow; Motoko Shiozaki; Taneaki Higashi; Kentaro Yoshimura; Masahiro Shibata; Eiki Kominami; Yasuo Uchiyama
Journal:  Histochem Cell Biol       Date:  2008-07-17       Impact factor: 4.304

2.  Unique Properties of Hepatocarcinogenesis-Resistant DRH Rat Hepatocytes Linked or Not Linked to the Drh1 Locus on Rat Chromosome 1.

Authors:  Norikazu Hashimoto; Masahiro Yamamoto; Masaaki Miyakoshi; Hiroki Tanaka; Katsuhiro Ogawa
Journal:  Int J Hepatol       Date:  2011-07-25

3.  Analyses of oxidative DNA damage and its repair activity in the livers of 3'-methyl-4-dimethylaminoazobenzene-treated rodents.

Authors:  T Hirano; K Higashi; A Sakai; Y Tsurudome; Y Ootsuyama; R Kido; H Kasai
Journal:  Jpn J Cancer Res       Date:  2000-07

4.  Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.

Authors:  S Mise-Omata; T Sugiura; K Higashi; U Yamashita
Journal:  Jpn J Cancer Res       Date:  1999-12

5.  The biphasic change of cytosolic acetyl-CoA hydrolase in rat liver during 3'-methyl-4-dimethylaminoazobenzene hepatocarcinogenesis.

Authors:  S Ebisuno; F Isohashi; Y Nakanishi; T Higashi; Y Sakamoto
Journal:  Jpn J Cancer Res       Date:  1989-02

Review 6.  Experimental Models to Define the Genetic Predisposition to Liver Cancer.

Authors:  Rosa M Pascale; Maria M Simile; Graziella Peitta; Maria A Seddaiu; Francesco Feo; Diego F Calvisi
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

7.  Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.

Authors:  Y Yan; K Higashi; K Yamamura; Y Fukamachi; T Abe; S Gotoh; T Sugiura; T Hirano; T Higashi; M Ichiba
Journal:  Jpn J Cancer Res       Date:  1998-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.